Beyond the landmark 2007 study, the broader body of evidence supporting GHK-Cu for hair includes: Follicle enlargement studies: Multiple in vitro studies confirm GHK-Cu increases the size of hair follicles, reversing miniaturization the key driver of visible thinning in androgenetic alopecia Anagen phase extension: Research confirms GHK-Cu extends the active growth phase of follicles, producing longer, thicker hairs per growth cycle Minoxidil comparison: Some studies suggest GHK-Cu performs comparably to 5% Minoxidil for hair growth stimulation through a more targeted, follicle-specific mechanism with a significantly better side effect profile Wound healing evidence: GHK-Cu's extensive wound healing evidence (accelerating tissue repair by 3040%) is directly relevant to scalp health the same repair mechanisms that heal damaged skin also support follicle recovery from inflammation and miniaturization damage Anti-inflammatory scalp research: GHK-Cu's consistent anti-inflammatory effects in skin tissue translate directly to scalp applications reducing the follicle-damaging inflammation that accelerates hair loss GHK-Cu vs Minoxidil: The Honest Comparison GHK-Cu and Minoxidil work through complementary mechanisms Minoxidil primarily through vasodilation, GHK-Cu primarily through direct follicle cell stimulation and anti-inflammatory action
One preclinical study in mice reported that ALCAR and alpha lipoic acid treatment improved spatial and temporal memory tests but only in mice with APOE4 [10]
Semaglutide (Rybelsus) is an oral GLP-1 agonist approved for type 2 diabetes, dosed at 3 mg, 7 mg, or 14 mg daily
These drugs are FDA-approved and are prescribed by doctors to treat obesity or overweight individuals who have other weight-related medical conditions such as high blood pressure, type 2 diabetes, or high cholesterol
Thats why I love sharing good news like last months approval
00967-0/asset/1cda1e69-507e-47d1-ad73-620bcd1cbb66/main.assets/gr2_lrg.jpg)
/assets/images/provider/photos/2775905.jpeg)
